Development of an HiBiT‐tagged reporter H3N2 influenza A virus and its utility as an antiviral screening platform

Chengcheng Zhang, Guoying Zhang, Yu Zhang, Xiaojing Lin, Xiujuan Zhao, Qinghua Cui, Lijun Rong, Ruikun DuJournal of Medical Virology 2022 · DOI

Abstract

The balance of the segmented genome derived from naturally occurring influenza A viruses (IAVs) is delicate and vulnerable to foreign insertions, thus most reporter IAVs up to date are generated using the backbone of the laboratory-adapted strains. In this study, we constructed a reporter influenza A/H3N2 virus (A/NY-HiBiT) which was derived from a clinical isolate, by placing a minimized HiBiT tag to the N-terminus of the viral nuclear-export protein (NEP). Here, we show that this 11-amino acid HiBiT tag did not adversely impact the viral genome balance, and the recombinant A/NY-HiBiT virus maintains its relative stability. Moreover, the replication profile of the HiBiT-tagged virus can be measured by a simple Nano-Glo assay, providing a robust high-throughput screening (THS) platform. We used this platform to evaluate a collection of the pre-purified fractions which were derived from rare Chinese medicinal materials, and we identified three fractions, including wild Trametes robiniophila (50% methanol fraction), Ganoderma (water fraction), and wild Phellinus igniarius (ethyl acetate fraction), as potent anti-IAV actives. Our results demonstrate that this IAV reporter can be used as a powerful HTS platform for antiviral development.
BibTeX
@article{zhang2022development,
  author = {Chengcheng Zhang and Guoying Zhang and Yu Zhang and Xiaojing Lin and Xiujuan Zhao and Qinghua Cui and Lijun Rong and Ruikun Du},
  title = {{Development of an HiBiT‐tagged reporter H3N2 influenza A virus and its utility as an antiviral screening platform}},
  journal = {Journal of Medical Virology},
  year = {2022},
  doi = {10.1002/jmv.28345},
}

Loading related content...

Figure